Market Overview

Poniard Pharma Beats EPS By $0.02 (PARD)

Poniard Pharma Reports ($0.11) Vs. ($0.13) Estimate (NASDAQ: PARD).

Posted-In: Earnings News

 

Most Popular

Related Articles (PARD)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free